European Association of Nuclear Medicine
Europe's nuclear medicine society, whose congress and guidelines shaped the clinical adoption of PSMA PET and lutetium radioligand therapy that began in European centres.
Founded in 1985 and based in Vienna, EANM represents nuclear medicine across Europe and publishes the European Journal of Nuclear Medicine and Molecular Imaging. Its annual congress is the largest nuclear medicine meeting in Europe and was the early forum for PSMA-PET and Lu-177 PSMA work from Heidelberg, Munich, Bad Berka and other centres before the VISION trial. EANM issues procedure guidelines with SNMMI on PSMA PET, PRRT for neuroendocrine tumours, dosimetry and FDG PET response criteria, runs the EARL accreditation programme that harmonises PET scanners across trial sites, and operates the European School of Multimodality Imaging and Therapy. It advocates on isotope supply and reimbursement for theranostics in Europe.
- EANM Congress
- EARL PET accreditation
- Procedure guidelines (with SNMMI)
- European Journal of Nuclear Medicine and Molecular Imaging
- ESMIT education
Nuclear medicine physician whose group invented FAPI PET tracers and pioneered PSMA and FAP radioligand therapy.
Frederik Giesel co-developed FAPI PET imaging and now leads nuclear medicine in Düsseldorf.
Clemens Kratochwil reported the first patients treated with actinium-225 PSMA therapy.
Pages like this
not linked directly; found by shared links- InstitutionChulabhorn Hospital / Chulabhorn Royal Academy
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, PET/CT.
- InstitutionTUM Klinikum rechts der Isar / CCC München
Shares LMU Klinikum München, Lutetium-177 dotatate, Theranostics, FAPI PET.
- IdeaA university cyclotron network with shared regulatory files for new tracers
Shares Frederik Giesel, Uwe Haberkorn, Heidelberg University Hospital / NCT / DKFZ, FAPI PET.
- InstitutionUniversity Hospital Düsseldorf / CIO Düsseldorf
Shares Frederik Giesel, Heidelberg University Hospital / NCT / DKFZ, FAPI PET, Lutetium-177 vipivotide tetraxetan.
- InstitutionIRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)
Shares Dosimetry, Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan.
- InstitutionInselspital, Bern University Hospital / University Cancer Center Inselspital
Shares Dosimetry, Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan.
- InstitutionPostgraduate Institute of Medical Education and Research, Chandigarh
Shares Lutetium-177 dotatate, FAPI PET, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- IdeaRegional radiopharmacy hubs and harmonised transport rules for short-lived isotopes
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, Radioligand therapy (beta emitters).